Eric Lefkofsky, Getty

Mar­ry­ing pre­ci­sion med and AI, Groupon co-founder Er­ic Lefkof­sky takes to­tal haul for his an­a­lyt­ics firm over the $1B line

The pan­dem­ic has tak­en Tem­pus — the com­pa­ny Groupon co-founder Er­ic Lefkof­sky launched to bring ar­ti­fi­cial in­tel­li­gence to physi­cians and re­searchers fo­cused on pre­ci­sion med­i­cine — in quite a few un­ex­pect­ed turns.

Not on­ly did it launch ef­forts to help doc­tors in their core field of can­cer adapt to new ways of work­ing, it al­so made a de­ci­sion to ex­pand in­to in­fec­tious dis­eases (start­ing with Covid-19), while dou­bling down on de­pres­sion and car­di­ol­o­gy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.